{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:47:16Z","timestamp":1775918836545,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81270035"],"award-info":[{"award-number":["81270035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81572796"],"award-info":[{"award-number":["81572796"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Pujiang Program","award":["15PJ1404900"],"award-info":[{"award-number":["15PJ1404900"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.canlet.2016.03.013","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T13:34:09Z","timestamp":1457703249000},"page":"83-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer"],"prefix":"10.1016","volume":"376","author":[{"given":"Xiaoyu","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canlet.2016.03.013_bib0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tcb.2006.03.001","article-title":"Gankyrin: a new oncoprotein and regulator of pRb and p53","volume":"16","author":"Dawson","year":"2006","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1016\/j.canlet.2016.03.013_bib0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/71600","article-title":"Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas","volume":"6","author":"Higashitsuji","year":"2000","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.canlet.2016.03.013_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccr.2005.06.006","article-title":"The oncoprotein gankyrin binds to MDM2\/HDM2, enhancing ubiquitylation and degradation of p53","volume":"8","author":"Higashitsuji","year":"2005","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.canlet.2016.03.013_bib0025","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1074\/jbc.M310265200","article-title":"The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53","volume":"279","author":"Krzywda","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.03.013_bib0030","series-title":"GLOBOCAN: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012","author":"International Agency for Research on Cancer, and World Health Organization","year":"2014"},{"issue":"15","key":"10.1016\/j.canlet.2016.03.013_bib0035","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.3748\/wjg.v20.i15.4178","article-title":"Targeting mTOR network in colorectal cancer therapy","volume":"20","author":"Wang","year":"2014","journal-title":"World J. Gastroenterol"},{"issue":"9","key":"10.1016\/j.canlet.2016.03.013_bib0040","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1245\/s10434-009-0555-9","article-title":"mTOR signaling pathway is a target for the treatment of colorectal cancer","volume":"16","author":"Zhang","year":"2009","journal-title":"Ann. Surg. Oncol"},{"issue":"1","key":"10.1016\/j.canlet.2016.03.013_bib0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibs.2003.11.007","article-title":"TSC2: filling the GAP in the mTOR signaling pathway","volume":"29","author":"Li","year":"2004","journal-title":"Trends Biochem. Sci"},{"issue":"10","key":"10.1016\/j.canlet.2016.03.013_bib0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.cellsig.2004.03.019","article-title":"The Rheb family of GTP-binding proteins","volume":"16","author":"Aspuria","year":"2004","journal-title":"Cell. Signal"},{"issue":"2","key":"10.1016\/j.canlet.2016.03.013_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/embor.2011.257","article-title":"Regulation of TOR by small GTPases","volume":"13","author":"Dur\u00e1n","year":"2012","journal-title":"EMBO Rep"},{"issue":"7","key":"10.1016\/j.canlet.2016.03.013_bib0060","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bbagrm.2014.11.006","article-title":"Translational control by oncogenic signaling pathways","volume":"1849","author":"Gao","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.canlet.2016.03.013_bib0065","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ccell.2014.09.008","article-title":"Rab1A Is an mTORC1 activator and a colorectal oncogene","volume":"26","author":"Thomas","year":"2014","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.canlet.2016.03.013_bib0070","doi-asserted-by":"crossref","first-page":"8539","DOI":"10.18632\/oncotarget.3816","article-title":"Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors","volume":"6","author":"Gupta","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.canlet.2016.03.013_bib0075","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.canlet.2016.03.013_bib0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ncb995","article-title":"Rheb is an essential regulator of S6K in controlling cell growth in Drosophila","volume":"5","author":"Stocker","year":"2003","journal-title":"Nat. Cell Biol"},{"issue":"29","key":"10.1016\/j.canlet.2016.03.013_bib0085","doi-asserted-by":"crossref","first-page":"19793","DOI":"10.1074\/jbc.C600028200","article-title":"Hyperactivation of mammalian target of rapamycin (mTOR) signaling by a gain-of-function mutant of the Rheb GTPase","volume":"281","author":"Yan","year":"2006","journal-title":"J. Biol. Chem"},{"issue":"15","key":"10.1016\/j.canlet.2016.03.013_bib0090","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev"},{"issue":"18","key":"10.1016\/j.canlet.2016.03.013_bib0095","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1128\/MCB.24.18.7965-7975.2004","article-title":"Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity","volume":"24","author":"Li","year":"2004","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.canlet.2016.03.013_bib0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(07)38021-X","article-title":"Characterization of the Rheb-mTOR signaling pathway in mammalian cells: constitutive active mutants of Rheb and mTOR","volume":"438","author":"Sato","year":"2008","journal-title":"Methods Enzymol"},{"issue":"13","key":"10.1016\/j.canlet.2016.03.013_bib0105","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1074\/jbc.C500451200","article-title":"TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase","volume":"281","author":"Chong-Kopera","year":"2006","journal-title":"J. Biol. Chem"},{"issue":"7","key":"10.1016\/j.canlet.2016.03.013_bib0110","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1101\/gad.1624008","article-title":"WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase","volume":"22","author":"Hu","year":"2008","journal-title":"Genes Dev"},{"issue":"5","key":"10.1016\/j.canlet.2016.03.013_bib0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrc3944","article-title":"Examining the utility of patient-derived xenograft mouse models","volume":"15","author":"Aparicio","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2016.03.013_bib0120","article-title":"Gankyrin regulates cell signaling network","author":"Wang","year":"2016","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.canlet.2016.03.013_bib0125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.27551","article-title":"Interleukin-1beta\/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis","volume":"61","author":"Su","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.canlet.2016.03.013_bib0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1476-4598-12-114","article-title":"LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin\/STAT3\/Akt pathway","volume":"12","author":"Song","year":"2013","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.canlet.2016.03.013_bib0135","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/cr.2011.103","article-title":"The oncoprotein p28GANK establishes a positive feedback loop in beta-catenin signaling","volume":"21","author":"Dong","year":"2011","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.canlet.2016.03.013_bib0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.24015","article-title":"p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase\/AKT\/hypoxia-inducible factor-1alpha pathways","volume":"53","author":"Fu","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.canlet.2016.03.013_bib0145","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/hep.26705","article-title":"Gankyrin promotes tumor growth and metastasis through activation of IL-6\/STAT3 signaling in human cholangiocarcinoma","volume":"59","author":"Zheng","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.canlet.2016.03.013_bib0150","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.canlet.2012.10.037","article-title":"Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN\/PI3K\/AKT signaling pathway","volume":"339","author":"Zhang","year":"2013","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.canlet.2016.03.013_bib0155","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI42542","article-title":"Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA\/ROCK pathway in mammalian cells","volume":"120","author":"Man","year":"2010","journal-title":"J. Clin. Invest"},{"issue":"54","key":"10.1016\/j.canlet.2016.03.013_bib0160","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination","volume":"19","author":"Benvenuto","year":"2000","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.canlet.2016.03.013_bib0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2013.01.010","article-title":"XLID CUL4B mutants are defective in promoting TSC2 degradation and positively regulating mTOR signaling in neocortical neurons","volume":"1832","author":"Wang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.canlet.2016.03.013_bib0170","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cellsig.2008.01.020","article-title":"Pam (Protein associated with Myc) functions as an E3 ubiquitin ligase and regulates TSC\/mTOR signaling","volume":"20","author":"Han","year":"2008","journal-title":"Cell. Signal"},{"issue":"1","key":"10.1016\/j.canlet.2016.03.013_bib0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/emmm.201201369","article-title":"The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling","volume":"5","author":"Wang","year":"2013","journal-title":"EMBO Mol. Med"},{"issue":"3","key":"10.1016\/j.canlet.2016.03.013_bib0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2443.2008.01162.x","article-title":"E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6","volume":"13","author":"Zheng","year":"2008","journal-title":"Genes Cells"},{"issue":"5","key":"10.1016\/j.canlet.2016.03.013_bib0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/onc.2013.589","article-title":"p53 suppresses carcinoma progression by inhibiting mTOR pathway activation","volume":"34","author":"Akeno","year":"2015","journal-title":"Oncogene"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516301616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516301616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T06:58:47Z","timestamp":1536908327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383516301616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0304383516301616"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2016.03.013","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2016.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}